About the Authors
University of Alabama at Birmingham Centre for Infectious Disease Research in Zambia, Lusaka, Zambia
Thailand Ministry of Public Health—US Centers for Disease Control and Prevention (CDC) Collaboration, Nonthaburi, Thailand
Global AIDS Program, CDC, Atlanta, Georgia, United States of America
Kenyatta National Hospital, Nairobi, Kenya
University of Nairobi, Nairobi, Kenya
Siriraj Hospital, Mahidol University, Bangkok, Thailand
Rajavithi Hospital, Bangkok, Thailand
Global AIDS Program, CDC-Zambia, Lusaka, Zambia
Global AIDS Program, CDC-Kenya, Nairobi, Kenya
Division of HIV/AIDS Prevention, CDC, Atlanta, Georgia, United States of America
University Teaching Hospital, Lusaka, Zambia
Northrup-Grumman Corporation, Atlanta, Georgia, United States of America
The authors have declared that no competing interests exist.
ICMJE criteria for authorship read and met: JSAS MSM JNK OB TA TJ DP WM CBB DMN PM JOO IZ LN BJ SP MB NS PW. Agree with the manuscript's results and conclusions: JSAS MSM JNK OB TA TJ DP WM CBB DMN PM JOO IZ LN BJ SP MB NS PW. Designed the experiments/the study: JSAS MSM JNK TA TJ DMN JOO IZ BJ NS PW. Analyzed the data: JSAS JNK OB TJ CBB JOO SP NS PW. Collected data/did experiments for the study: MSM JNK TA TJ DP PM JOO LN. Enrolled patients: MSM JNK TA TJ DP PM JOO LN BJ. Wrote the first draft of the paper: JSAS TJ CBB PW. Contributed to the writing of the paper: JSAS MSM JNK OB TA TJ DP WM CBB DMN PM JOO IZ MB NS PW. Supervised the study: JSAS. Developed the protocol, and responsible for study implementation and data collection and integrity at two sites: MSM. Participated in the coordination of the study, and helped to provide technical input and support: OB. Provided administrative supervision and support during study implementation as the Project Officer in charge of the program; reviewed and contributed to writing of the study protocol for Kenya: WM. Contributed to discussions of data and results: IZ. Responsible for data integrity: LN. Responsible for data integrity and quality: SP. Provided leadership in development of the protocol, IRB clearance, securing funding, organizing collaborator meetings, and communications: NS.